The effects of dexamethasone on cigarette smoke induced gene expression changes in COPD macrophages
Authors:
- 1 January 2010
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 10 (1) , 57-64
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Inhibition of Lipopolysaccharide-Stimulated Chronic Obstructive Pulmonary Disease Macrophage Inflammatory Gene Expression by Dexamethasone and the p38 Mitogen-Activated Protein Kinase Inhibitor N-cyano-N′-(2-{[8-(2,6-difluorophenyl)-4-(4-fluoro-2-methylphenyl)-7-oxo-7,8-dihydropyrido[2,3-d] pyrimidin-2-yl]amino}ethyl)guanidine (SB706504)The Journal of Pharmacology and Experimental Therapeutics, 2009
- Different Mitogen-Activated Protein Kinase-Dependent Cytokine Responses in Cells of the Monocyte LineageThe Journal of Pharmacology and Experimental Therapeutics, 2008
- A Pooled Analysis of FEV 1 Decline in COPD Patients Randomized to Inhaled Corticosteroids or PlaceboChest, 2007
- Corticosteroids: The drugs to beatEuropean Journal of Pharmacology, 2006
- Combinatorial roles of nuclear receptors in inflammation and immunityNature Reviews Immunology, 2005
- Molecular Determinants of Crosstalk between Nuclear Receptors and Toll-like ReceptorsCell, 2005
- Theophylline Restores Histone Deacetylase Activity and Steroid Responses in COPD MacrophagesJournal of Experimental Medicine, 2004
- New Concepts in Chronic Obstructive Pulmonary DiseaseAnnual Review of Medicine, 2003
- Impaired Inhibition by Dexamethasone of Cytokine Release by Alveolar Macrophages from Patients with Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Inhibition of LPL Expression in Human Monocyte–Derived Macrophages Is Dependent on LDL Oxidation StateArteriosclerosis, Thrombosis, and Vascular Biology, 1998